ImmuPharma plc (LON:IMM – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1.98 ($0.03) and traded as high as GBX 1.99 ($0.03). ImmuPharma shares last traded at GBX 1.96 ($0.03), with a volume of 259,624 shares changing hands.
ImmuPharma Stock Up 2.0 %
The stock has a fifty day simple moving average of GBX 1.67 and a 200-day simple moving average of GBX 1.98. The company has a market capitalization of £8.31 million, a P/E ratio of -195.50 and a beta of 1.53.
ImmuPharma Company Profile
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
See Also
- Five stocks we like better than ImmuPharma
- 5 Top Rated Dividend Stocks to Consider
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Earnings Per Share Calculator: How to Calculate EPS
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
